Impact of Corticosteroids on Efficacy of BCMA Targeted CAR-T Therapy in Multiple Myeloma

被引：2
作者：
Duvalyan, Eva [1 ]
Lo, Mimi [2 ]
Martin, Thomas [3 ]
Wolf, Jeffrey L. [3 ]
Chung, Alfred [3 ]
Arora, Shagun [3 ]
Shah, Nina [3 ]
Huang, Chiung-Yu [3 ]
Wong, Sandy W. [3 ]
机构：
[1] Univ Calif San Francisco, Sch Med, San Francisco, CA USA
[2] Univ Calif San Francisco, Dept Pharmaceut Serv, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, San Francisco, CA 94143 USA
来源：
BLOOD | 2021年 / 138卷
关键词：
D O I：
10.1182/blood-2021-146678
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1759
引用
收藏
页数：5
相关论文
共 50 条
  • [31] FDA approves second BCMA-targeted CAR-T cell therapy
    Mullard, Asher
    NATURE REVIEWS DRUG DISCOVERY, 2022, 21 (04) : 249 - 249
  • [32] Are we there yet? CAR-T therapy in multiple myeloma
    Mirvis, Eitan
    Benjamin, Reuben
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (06) : 2175 - 2189
  • [33] Anti-BCMA CAR-T cell immunotherapy for relapsed or refractory multiple myeloma
    Zhang, Xiaohui
    Ouyang, Chenxi
    Sun, Guofeng
    Liu, Hongfeng
    Qi, Junyuan
    Suo, Xiaohui
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 26 (04)
  • [34] Anti-BCMA CAR-T therapy for multiple myeloma with extramedullary disease: A case report and review of the literature
    Shi, Huihui
    Zhang, Man
    Su, Yajing
    Liu, Jingwen
    Guo, Jiayuan
    Liu, Mingxin
    Ma, Qiuling
    MEDICINE, 2024, 103 (26)
  • [35] BCMA-BBZ-OX40 CAR-T Therapy Using an Instant Manufacturing Platform in Multiple Myeloma
    Wang, Ting
    Yang, Yazi
    Ma, Lie
    Feng, Ru
    Li, Jiangtao
    Zhang, Chunli
    Bai, Jiefei
    Ding, Yanping
    Liu, Guanghua
    Wu, Fei
    Lu, Xinan
    Feng, Shi
    Li, Zhenling
    He, Ting
    Li, Jian
    Liu, Hui
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (09)
  • [36] BCMA CAR-T cells in multiple myeloma-ready for take-off?
    Scheller, Lukas
    Tebuka, Erius
    Rambau, Peter Fabian
    Einsele, Hermann
    Hudecek, Michael
    Prommersberger, Sabrina Rebecca
    Danhof, Sophia
    LEUKEMIA & LYMPHOMA, 2024, 65 (02) : 143 - 157
  • [37] Developing a Novel Anti-Bcma CAR-T for Relapsed or Refractory Multiple Myeloma
    Yao, Xin
    Zhu, Shigui
    Huang, Jiaqi
    Qu, Xiaoyan
    Zhu, Judy
    Wei, Yutian
    Lan, Liping
    Lv, Xiaoteng
    Wu, Junfeng
    Wang, Rirfei
    Yang, Dingzhu
    Zheng, Chengxiao
    Zhao, DiJun
    Fan, Lei
    Huang, Fei
    Lu, Hua
    Zhang, Chaocan
    Chen, Cheng
    Li, Yanfeng
    Ren, Jiaqiang
    Zhang, Li
    Humphries, Michael
    Li, Jianyong
    Yao, Yihong
    BLOOD, 2019, 134
  • [38] Molecular Mechanisms Promoting Long-Term Cytopenia after BCMA CAR-T Therapy in Multiple Myeloma
    不详
    BLOOD, 2024, 144 : 4798 - 4799
  • [39] Mechanisms and salvage treatments in patients with multiple myeloma relapsed post-BCMA CAR-T cell therapy
    Fu, Bingjie
    Liu, Rui
    Gao, Gongzhizi
    Lin, Zujie
    He, Aili
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [40] BCMA CAR-T Therapy Is Safe and Effective for Refractory/Relapsed Multiple Myeloma With Central Nervous System Involvement
    Wang, Yiyun
    Zu, Cheng
    Teng, Xinyi
    Yang, Li
    Zhang, Mingming
    Hong, Ruimin
    Zhao, Houli
    Cui, Jiazhen
    Xu, Huijun
    Hongsheng, Alex Chang
    Hu, Yongxian
    Huang, He
    JOURNAL OF IMMUNOTHERAPY, 2022, 45 (01) : 25 - 34
12345